ADMS - Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q3 2020 Results -Earnings Call Transcript

Adamas Pharmaceuticals, Inc. (ADMS) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Peter Vozzo – Investor Relations Neil McFarlane – Chief Executive Officer Vijay Shreedhar – Chief Commercial Officer Chris Prentiss – Chief Financial Officer Conference Call Participants Zachary Sachar – Piper Sandler John Boyle – William Blair Rudy Li – SVB Leerink Presentation Operator Welcome to the Adamas Pharmaceuticals Third Quarter 2020 Financial Results and Corporate Update Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] I would now like to turn the conference over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead. Peter Vozzo Thank you, Ryan, and good afternoon, everyone. On the call with me are Neil McFarlane, Chief Executive Officer; Vijay Shreedhar, Chief Commercial Officer; and Chris Prentiss, Chief Financial Officer Before we begin, I would like to remind everyone that this

For further details see:

Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q3 2020 Results -Earnings Call Transcript